Products - Parkinson's disease, tremor and dystonia | Topic | NICE

Showing 3 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Deutetrabenazine for treating tardive dyskinesia [ID6550]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Levodopa inhaled for patients with Parkinson’s disease who experience ‘off’ episodes (motor response fluctuations) [TSID8778]
Status:
Topic prioritisation
Programme:
Technology appraisal guidance
Expected publication date:
TBC
MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor
Status:
In development | In consultation
Programme:
Interventional procedures guidance
Consultation end date:
11 February 2026
Expected publication date:
TBC